Document is current
Any future updates will be listed below
-
Authors
Pinto-Medel, María Jesús https://orcid.org/0000-0002-1129-7415
Oliver-Martos, Begoña
Urbaneja-Romero, Patricia
Hurtado-Guerrero, Isaac
Ortega-Pinazo, Jesús
Serrano-Castro, Pedro https://orcid.org/0000-0002-3414-2707
Fernández, Óscar
Leyva, Laura
- License Information
-
More Information
Article History
Received: 4 April 2017
Accepted: 25 July 2017
First Online: 18 August 2017
Competing Interests
: PSC has received honoraria or served as a paid consultant for BIAL, EISAI, ESTEVE, Juste, UCB-Pharma, Sanofi and Shire. OF reports receiving honoraria as a consultant in advisory boards, as chair/lecturer in meetings, from participation in clinical trials and other research projects promoted by Actelion, Allergan, Almirall, Bayer-Schering, Biogen, Merck Serono, Novartis, Sanofi Genzyme, and Teva, and research support from the Hospital Foundation FIMABIS; he also serves as editor of the Revista Española de Esclerosis Múltiple. The other authors declare that they have no competing interests.
